# Centre de Recherches en Cancérologie de Toulouse

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/centre-de-recherches-en-cancerologie-de-toulouse/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 65 |
| Citations | 584,317 |
| City | Toulouse |
| Country | FR |
| Description | Centre de Recherches en Cancérologie de Toulouse is a research organisation in Toulouse, FR. OpenAlex records 4,150 works and 584,317 citations for it. 1,053 researchers list it as their most recent affiliation. |
| Homepage | https://www.crct-inserm.fr |
| OpenAlex ID | https://openalex.org/I4210087620 |
| Region | Occitanie |
| Researchers | 1,053 |
| ROR ID | https://ror.org/003412r28 |
| Type | facility |
| Wikidata ID | Q30264420 |
| Works | 4,150 |

## University papers

- [Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study](https://scholariq.org/papers/pembrolizumab-versus-methotrexate-docetaxel-or-cetuximab-for-recurrent-or/)
- [Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial](https://scholariq.org/papers/lurbinectedin-as-second-line-treatment-for-patients-with-small-cell-lung-cancer/)
- [Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study](https://scholariq.org/papers/evaluation-of-bgj398-a-fibroblast-growth-factor-receptor-1-3-kinase-inhibitor-in/)
- [Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors](https://scholariq.org/papers/phase-ib-trial-with-birabresib-a-small-molecule-inhibitor-of-bromodomain-and/)

## University top topics

Showing 8 of 25.

- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.